Testing effectiveness (Phase 2)Study completedNCT02366312
What this trial is testing
A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors
Who this might be right for
Keratocystic Odontogenic Tumor
NYU College of Dentistry 2